Treats major depressive disorder (MDD). ANDA 72192, held by Oxford Pharms. Trazodone Hydrochloride.
As of Nov 16, 2026, ANDA 72192 (Trazodone Hydrochloride), held by Oxford Pharms, was first approved by FDA on Feb 2, 1989, with 31 approved supplements and 0 published complete response letters.
Trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 2, 1989 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Trazodone Hydrochloride50MG · tablet;oral | Trazodone Hydrochloride | Rx |
| Jun 24, 2025 | Supplement 58Labeling · Standard review | Approved | None posted |
| May 19, 2020 | Supplement 54Labeling · Standard review | Approved | None posted |
| May 19, 2020 | Supplement 51Labeling · Standard review | Approved | None posted |
| Jun 15, 2015 | Supplement 46Labeling · Standard review | Approved | None posted |
| May 12, 2015 | Supplement 41Manufacturing | Approved | None posted |
| Oct 29, 2007 | Supplement 40Labeling | Approved | None posted |
| Jun 26, 2007 | Supplement 39Labeling | Approved | None posted |
| Aug 15, 2005 | Supplement 37Labeling | Approved | None posted |
| Jan 5, 2005 | Supplement 31Labeling | Approved | None posted |
| Dec 26, 2002 | Supplement 29Labeling | Approved | None posted |
| Feb 20, 2002 | Supplement 28Manufacturing | Approved | None posted |
| Jan 4, 2001 | Supplement 27Labeling | Approved | None posted |
| May 26, 2000 | Supplement 24Labeling | Approved | None posted |
| May 26, 2000 | Supplement 23Manufacturing | Approved | None posted |
| Dec 2, 1999 | Supplement 26Manufacturing | Approved | None posted |
| Dec 2, 1999 | Supplement 25Manufacturing | Approved | None posted |
| Feb 12, 1999 | Supplement 16Manufacturing | Approved | None posted |
| Feb 12, 1999 | Supplement 15Manufacturing | Approved | None posted |
| Feb 18, 1998 | Supplement 14Manufacturing | Approved | None posted |
| Oct 9, 1997 | Supplement 13Manufacturing | Approved | None posted |
| May 7, 1997 | Supplement 12Manufacturing | Approved | None posted |
| Dec 11, 1996 | Supplement 11Manufacturing | Approved | None posted |
| Aug 16, 1996 | Supplement 10Manufacturing | Approved | None posted |
| Apr 30, 1996 | Supplement 9Manufacturing | Approved | None posted |
| May 5, 1993 | Supplement 8Manufacturing | Approved | None posted |
| Apr 6, 1992 | Supplement 6Manufacturing | Approved | None posted |
| Apr 6, 1992 | Supplement 4Manufacturing | Approved | None posted |
| Apr 6, 1992 | Supplement 2Manufacturing | Approved | None posted |
| Mar 4, 1992 | Supplement 7Labeling | Approved | None posted |
| Sep 13, 1991 | Supplement 5Labeling | Approved | None posted |
| Aug 22, 1991 | Supplement 3Manufacturing | Approved | None posted |
| Feb 2, 1989 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters